Sound waves boost chemo to fight liver tumors in pancreatic cancer patients
NCT ID NCT07314385
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase study tests a new approach for people with pancreatic cancer that has spread to the liver and who have already tried standard chemotherapy. The treatment combines standard chemotherapy drugs with a special ultrasound technique that uses tiny bubbles to help deliver the medication directly into liver tumors. The main goals are to check safety and find the best dose of the bubble agent.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER METASTASIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Taiwan University Hospital
Taipei, 100, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a smart drug home in on Hard-to-Treat cancers?
- New ultrasound technique could reveal hidden blood vessels in liver tumors
- Scientists hunt for weaknesses in pancreatic Cancer's fuel system
- Study aims to cut hospital time after liver surgery by looking beyond medicine
- New drug combo aims to tackle deadly pancreatic cancer
- New hope for hard-to-treat pancreatic cancer: targeted drug combo enters phase 3 trial